Myelodysplastic syndrome after cisplatin therapy
نویسندگان
چکیده
منابع مشابه
Differentiation therapy for myelodysplastic syndrome.
Nearly 20 years ago in 1982, one of us wrote a review for Blood about the therapeutic potential of differentiation therapy (1). This was shortly after the initial studies with HL-60 myeloblastic leukemia cells showing that a variety of agents, including retinoids, could induce their terminal differentiation. This was followed by the finding that retinoids, especially ATRA, could cause terminal ...
متن کاملTherapy-related myelodysplastic syndrome: a case study.
We present a case of therapy-related myelodyspastic syndrome in which the t(3;8)(q26;q24) translocation appeared, even though no chromosomal abnormalities were found at the initial diagnosis of acute myeloid leukemia. To the best of our knowledge, there have only been around 20 reported cases of myeloid malignancies involving t(3;8)(q26;q24). We discuss the characteristics of t(3;8)(q26;q24) al...
متن کاملMyelodysplastic syndrome after autologous transplant for lymphoma.
Certain aspects of the article by Miller et all reporting myelodysplastic syndrome (MDS) after autologous stem cell transplant for lymphoma and the accompanying editorial by Stone’ deserve comment. Miller et a1 estimated the cumulative incidence of MDS as 14.5% at 5 years after autologous transplant for lymphoma using the method of Kaplan and Meier. The Kaplan-Meier analysis of these data may n...
متن کاملComplete Remission of del(5q) Myelodysplastic Syndrome after 7 Days of Lenalidomide Therapy Gives an Alert!
Myelodysplastic syndrome (MDS) refers to a group of haematological, monoclonal disorders. A 50-year-old woman was diagnosed with MDS 5q deletion syndrome [del(5q)], becoming dependent on blood transfusion after long-term treatment with cytotoxic drugs for chronic scleritis. Lenalidomide therapy (10 mg/day) led to profound pancytopaenia, followed by recovery of her blood cell counts. A cytogenet...
متن کاملMyelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy.
Myelodysplastic syndrome (MDS) is a complication of conventional antineoplastic therapy but has rarely been reported after autologous bone marrow transplantation (ABMT). We reviewed records of 206 patients who underwent ABMT for lymphoma at the University of Minnesota (Minneapolis, MN) between 1974 and 1993. Of 206 patients who underwent ABMT for non-Hodgkin's lymphoma (NHL) or Hodgkin's diseas...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Cancer
سال: 1993
ISSN: 0008-543X,1097-0142
DOI: 10.1002/1097-0142(19930701)72:1<213::aid-cncr2820720138>3.0.co;2-i